It is a pharma private limited company based in Manimajra, Chandigarh, India, established in 2016.
2016 | Manimajra, Chandigarh, India | ActiveGat Pharmaceuticals Private Limited, a active private limited company, was established on 13 October 2016 in Manimajra, Chandigarh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999CH2016PTC041251. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Ashish Pundir (Director), Gajender Singh (Director). Past directors included Tejpal Chauhan, Aaditya Tanwar. It holds ₹1.20 M open charges and no settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at First Floor Shop No. 1139/14 Govindpura, Manimajra, Chandigarh, 160101.
U74999CH2016PTC041251
041251
13 October 2016
₹1.00 M
₹1.00 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Gat Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashish Pundir | Director | 13 Oct 2016 | Current |
| Gajender Singh | Director | 13 Oct 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 May 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gat Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Gat Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,200,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Sep 2018 | Syndicate Bank | ₹0.30 M | Open |
| 20 Jan 2017 | Syndicate Bank | ₹0.90 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Gat Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Gat Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gat Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Gat Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
The activity Gat Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Chandigarh. was completed.
The activity A charge with Syndicate Bank amounted to Rs. 0.30 M with Charge ID 100208589 was registered on 17 Sep 2018. was completed.
The activity A charge with Syndicate Bank amounted to Rs. 0.90 M with Charge ID 100125903 was registered on 20 Jan 2017. was completed.
Ashish Pundir was appointed as a Director was appointed as a Director on 13 Oct 2016 & has been associated with this company since 9 years 1 month . was recorded as a recent event.
Progress on Gajender Singh was appointed as a Director was appointed as a Director on 13 Oct 2016 & has been associated with this company since 9 years 1 month . was documented.
The CIN of Gat Pharmaceuticals Private Limited is U74999CH2016PTC041251.
Gat Pharmaceuticals Private Limited is headquartered at First Floor Shop No. 1139/14 Govindpura, Manimajra, Chandigarh, 160101.
Gat Pharmaceuticals Private Limited was incorporated on 13 October 2016.
The current directors of Gat Pharmaceuticals Private Limited are
The primary industry of Gat Pharmaceuticals Private Limited is Trade.
Gat Pharmaceuticals Private Limited is unlisted.
The authorized capital of Gat Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Gat Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX